In the pharmaceutical industry, Sodium Feredetate (also known as Sodium Iron Edetate) is a unique iron chelate. As a pharmacist and manufacturer, I view this molecule as a “Technically Superior Iron Source”—it is a stable complex of iron and EDTA (Ethylenediaminetetraacetic acid) designed specifically to overcome the common limitations of traditional iron salts like Ferrous Sulfate.
At your WHO-GMP facility in Mumbai, Sodium Feredetate is a high-value SKU for your hematology and maternal health portfolios. For your digital platforms, highlighting its “Chelation Stability” is a major technical differentiator for clinician and B2B buyer interest.
Therapeutic Profile: Primary Benefits
Sodium Feredetate is the preferred iron supplement for patients who cannot tolerate standard iron preparations due to gastric distress or poor absorption.
| Benefit | Clinical Impact | Technical Rationale |
| Superior Tolerability | Low GI Side Effects | The iron remains bound in a chelate complex until it reaches the duodenum, preventing free iron from irritating the stomach lining. |
| High Bioavailability | Effective Absorption | Absorbed as an intact complex; it is less affected by dietary inhibitors like phytates or tannins found in tea and cereals. |
| No Teeth Staining | Aesthetic Advantage | Unlike liquid Ferrous Sulfate, Sodium Feredetate does not react with tooth enamel to cause black staining, making it ideal for pediatric syrups. |
| Food Compatibility | Dosing Flexibility | Can be taken with meals without a significant reduction in iron uptake, unlike most other oral iron salts. |
Mechanism: Controlled Release Chelation
Sodium Feredetate works through a “Shielded Transport” mechanism:
Gastric Stability: In the acidic environment of the stomach, the iron-EDTA complex remains tightly bound, protecting the gastric mucosa from oxidative stress.
Duodenal Release: Upon reaching the slightly more alkaline environment of the small intestine, the complex slowly releases the iron for absorption via the divalent metal transporter (DMT1).
Oxidation Prevention: Technically, the EDTA “shield” prevents the iron from reacting with other nutrients, ensuring that the iron reaches its target in the correct valence state ($Fe^{3+}$).
The Pharmacist’s “Technical Warning”
-
The “EDTA” Consideration: As a pharmacist, I must note that because it contains EDTA, this medication should not be used in patients with lead poisoning, as it may interfere with lead chelation therapy.
-
Overdose Risk: While safer than Ferrous Sulfate, it still contains elemental iron (typically ~33 mg per 231 mg tablet). Keep out of reach of children, as iron overdose is a medical emergency.
-
Interaction with Antibiotics: Like all iron products, it can reduce the absorption of Tetracyclines and Quinolones. A 2-hour gap between doses is technically required.
-
Stool Discoloration: Patients should be reassured that black or dark-colored stools are a harmless side effect of unabsorbed iron and do not indicate internal bleeding.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
-
The “Pediatric & Prenatal” USP: On your digital marketplace, position Sodium Feredetate as the “Gold Standard for Compliance.” Since it lacks the metallic “aftertaste” of other irons, it is the best candidate for your pediatric drops and maternal tonic formulations.
-
Stability for Export: Sodium Feredetate is highly stable and less prone to oxidation than Ferrous Fumarate. Utilizing Alu-Alu blister packaging or high-quality PET bottles for syrups ensures a 36-month shelf life in Zone IVb tropical regions.
-
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers to support your firm’s registration in international tenders for anemia control and nutritional fortification programs.